Suppr超能文献

2022年世界泌尿外科联合会/国际泌尿外科协会肾细胞癌泌尿疾病国际咨询会:遗传学与肿瘤微环境

2022 WUOF/SIU International Consultation on Urological Diseases: Genetics and Tumor Microenvironment of Renal Cell Carcinoma.

作者信息

Khaleel Sari, Ricketts Christopher, Linehan W Marston, Ball Mark, Manley Brandon, Turajilic Samra, Brugarolas James, Hakimi Ari

机构信息

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, United States.

出版信息

Soc Int Urol J. 2022 Nov;3(6):386-396. doi: 10.48083/BLPV3411.

Abstract

Renal cell carcinoma is a diverse group of diseases that can be distinguished by distinct histopathologic and genomic features. In this comprehensive review, we highlight recent advancements in our understanding of the genetic and microenvironmental hallmarks of kidney cancer. We begin with clear cell renal cell carcinoma (ccRCC), the most common subtype of this disease. We review the chromosomal and genetic alterations that drive initiation and progression of ccRCC, which has recently been shown to follow multiple highly conserved evolutionary trajectories that in turn impact disease progression and prognosis. We also review the diverse genetic events that define the many recently recognized rare subtypes within non-clear cell RCC. Finally, we discuss our evolving understanding of the ccRCC microenvironment, which has been revolutionized by recent bulk and single-cell transcriptomic analyses, suggesting potential biomarkers for guiding systemic therapy in the management of advanced ccRCC.

摘要

肾细胞癌是一组具有多种类型的疾病,可通过独特的组织病理学和基因组特征加以区分。在这篇全面综述中,我们重点介绍了我们对肾癌遗传和微环境特征认识的最新进展。我们首先从透明细胞肾细胞癌(ccRCC)开始,它是这种疾病最常见的亚型。我们回顾了驱动ccRCC起始和进展的染色体和基因改变,最近研究表明其遵循多个高度保守的进化轨迹,进而影响疾病进展和预后。我们还回顾了定义非透明细胞肾细胞癌内许多最近才被认识的罕见亚型的各种基因事件。最后,我们讨论了我们对ccRCC微环境不断演变的理解,最近的大量和单细胞转录组分析彻底改变了这一理解,为晚期ccRCC管理中指导全身治疗提示了潜在的生物标志物。

相似文献

4
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Eur Urol Focus. 2019 Jul;5(4):608-618. doi: 10.1016/j.euf.2018.01.016. Epub 2018 Feb 13.
9
10
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma.
J Cancer Res Clin Oncol. 2023 Nov;149(17):16015-16030. doi: 10.1007/s00432-023-05349-y. Epub 2023 Sep 9.

引用本文的文献

1
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
Int J Mol Sci. 2023 Feb 27;24(5):4615. doi: 10.3390/ijms24054615.

本文引用的文献

3
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Eur Urol Focus. 2022 Sep;8(5):1278-1288. doi: 10.1016/j.euf.2021.12.002. Epub 2022 Mar 11.
6
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.
Cancer Cell. 2021 May 10;39(5):662-677.e6. doi: 10.1016/j.ccell.2021.03.007. Epub 2021 Apr 15.
7
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Cancer Cell. 2021 May 10;39(5):632-648.e8. doi: 10.1016/j.ccell.2021.02.013. Epub 2021 Mar 11.
8
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Cancer Cell. 2021 May 10;39(5):649-661.e5. doi: 10.1016/j.ccell.2021.02.015. Epub 2021 Mar 11.
9
Immune checkpoint blockade in renal cell carcinoma.
J Surg Oncol. 2021 Mar;123(3):739-750. doi: 10.1002/jso.26339.
10
MiT/TFE Family of Transcription Factors: An Evolutionary Perspective.
Front Cell Dev Biol. 2021 Jan 6;8:609683. doi: 10.3389/fcell.2020.609683. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验